Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.
about
Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisInterleukin-1 receptor antagonist intervenes in signaling between different types of synoviocytes in rats with adjuvant arthritis.Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts--from the point of view of mouse genomics.Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.Cooperative role of tumour necrosis factor-α, interleukin-1β and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice.Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritisDivergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venulesSystemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophilsIL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP)Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration responseInterleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes.Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis.Phospholipase D1 has a pivotal role in interleukin-1β-driven chronic autoimmune arthritis through regulation of NF-κB, hypoxia-inducible factor 1α, and FoxO3aPhysiologic deformational loading does not counteract the catabolic effects of interleukin-1 in long-term culture of chondrocyte-seeded agarose constructs.New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment.Regulation of TNF-α with a focus on rheumatoid arthritis.Mechanisms of spontaneous resolution of acute gouty inflammation.Genipin enhances the mechanical properties of tissue-engineered cartilage and protects against inflammatory degradation when used as a medium supplement.In silico and in vitro immunomodulatory studies on compounds of Lindelofia stylosa.Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.A study on interleukin -1β and lipid profile as markers of cardiovascular risk in rheumatoid arthritisOncostatin M decreases interleukin-1 β secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo.Galectin-3: A Positive Regulator of Leukocyte Recruitment in the Inflamed Microcirculation.Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge.A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.T cell subsets: an integral component in pathogenesis of rheumatic heart disease.Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist.10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells.Polimorphisms in Inflammasome Genes Are Involved in the Predisposition to Systemic Lupus Erythematosus
P2860
Q27022559-4C9058C2-83B2-4B28-B127-1BC307B280B2Q33229888-8E6D394F-74CA-40AE-8EFF-85177B8FD8C4Q33923325-B5A79ADF-0EF8-458B-9B6F-A3958D7CBB4BQ34081473-B4897042-6C42-4857-A0DE-60D15384BFD5Q34420356-0AECBD1E-1412-4E4F-8D99-AEDA27252263Q34449716-DACA1472-FD16-478D-BA4F-ED1AF97901C6Q34897610-1EC9505F-6786-45E1-B196-30B6D38D2752Q35044815-001AECED-9636-411C-A176-2B99D63E6AFAQ35537789-AA194653-C3FB-4256-AE16-74D843E5DC56Q35560901-74512443-563A-4C5E-BCBA-692FC4D9B798Q36667157-4CAF9385-8AEA-44E5-A08A-4CDDBB181C75Q36701444-862FA233-19A9-4267-9512-077A245D298EQ36891043-5F1FF671-9179-49B9-AB34-D56F87D55354Q36978352-E21F5598-49F5-43B0-9E6A-AD90DBCA4DA1Q37299450-90822D22-BF73-494C-8CCC-526EBA0E03B0Q38057370-1ABAA72A-537B-44F1-A7E9-FEEED74F366AQ38102876-C8D8D8F7-8D26-4F81-9225-23E7492BCB6AQ38171695-0500EEC3-36A9-4205-B3CD-D5EBA72B44A2Q39277177-8F7CC467-3BEA-495C-A851-7E47E0B5367CQ39425746-04573BD8-D325-4AE7-9F89-754DCC3E9346Q40147920-68AFE1E1-9BE8-42CC-98D6-D6697DC244C6Q42069543-026B8323-A8D7-4B0D-A14F-8612C43216CDQ42914271-ABC0A133-9A24-4B49-B116-E680A9643301Q45193683-03999D71-6EAC-4E91-8D02-7D0B3F638FC7Q46413567-FAD9A3D6-24D0-4302-9D29-CC76FE4D0680Q47230436-870CC906-7DD9-421A-A437-B15003CF6AADQ47239199-FE2F9526-15BD-4528-BF1E-61CE386C8F96Q47369105-7350AD48-4A6F-46C5-BDE6-7572A85FD43FQ52730350-740BD5B5-7D05-4B30-912A-EFC71432F2BDQ55517975-9694943B-3A09-404E-A560-93914F52917FQ58851155-5EAE8DC1-EB74-441F-AC5F-BE657D2DFF48
P2860
Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@ast
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@en
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@nl
type
label
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@ast
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@en
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@nl
prefLabel
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@ast
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@en
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@nl
P2860
P1476
Role of interleukin 1 and inte ...... ation of rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1136/ARD.59.SUPPL_1.I103
P407
P478
59 Suppl 1
P577
2000-11-01T00:00:00Z